| Product NDC: | 0904-2364 |
| Proprietary Name: | Methocarbamol |
| Non Proprietary Name: | Methocarbamol |
| Active Ingredient(s): | 500 mg/1 & nbsp; Methocarbamol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0904-2364 |
| Labeler Name: | Major Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA085159 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19760811 |
| Package NDC: | 0904-2364-40 |
| Package Description: | 500 TABLET in 1 BOTTLE (0904-2364-40) |
| NDC Code | 0904-2364-40 |
| Proprietary Name | Methocarbamol |
| Package Description | 500 TABLET in 1 BOTTLE (0904-2364-40) |
| Product NDC | 0904-2364 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methocarbamol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19760811 |
| Marketing Category Name | ANDA |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | METHOCARBAMOL |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |